ArticleChina CDC weekly2025
Risk Factors for Imported Severe Malaria Cases - China, 2019-2023.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Estimating the burden of imported malaria in the Asia Pacific region: a systematic review and meta-analysis.Journal of travel medicine · 2026Pooled it
- Epidemiological Characteristics, Risk Factors, and Countermeasures of Imported Malaria - China, 2017-2024.China CDC weekly · 2026Article
- Development of human resources in malaria microscopy during and after the malaria elimination phase in China.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze the epidemiological characteristics of imported malaria in China from 2019 to 2023 and to explore risk factors for severe malaria cases, thereby providing a theoretical basis for early clinical identification and intervention of severe malaria. Methods: National malaria case data were retrospectively collected from 2019 to 2023 through the Chinese Center for Disease Control and Prevention Parasitic Disease Prevention and Control Information System. Study subjects were divided into severe and non-severe malaria cases, and the characteristics of both groups were analyzed. Multivariate logistic regression analysis was used to explore risk factors for developing severe malaria. Results: From 2019 to 2023, a total of 7,892 imported malaria cases were reported nationwide, including 673 severe cases and 7,219 non-severe cases. There were 7,353 (93.2%) male and 539 (6.8%) female patients. Compared to non-severe malaria patients, severe malaria patients were older (43.9±10.4 years), predominantly originated from Africa (643,95.5%), had a higher frequency of recent overseas residence within the past month (609,90.5%), were typically infected with Conclusions: This study identified risk factors for severe malaria and recommends focusing on monitoring patients' age, infection source,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.